Nexien BioPharma Inc.
Intellectual Property with Pre-clinical and Clinical Drug Development
Nexien has an expanding intellectual property portfolio of exclusive licensed technology, provisional patents, and certain allowed patents, for the use of cannabinoids as pharmaceutical API`s for the treatment of targeted medical conditions.
Most popular related searches
advanced drug delivery
clinical drug development
drug delivery
drug development
preclinical drug development
preclinical drug
cannabinoid
clinical development
pharmaceuticals
Nexien also has an exclusive license to a patented drug delivery mechanism for the use of cannabinoids in human and veterinary applications. This patented tablet technology offers uniquely accurate and variable dosing within one core tablet design.